Patents by Inventor Andrew Gardner
Andrew Gardner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11966774Abstract: Methods, systems, and apparatus, including computer programs encoded on computer-readable media, for workflow generation using multiple interfaces. In some implementations, an interface for defining a workflow having one or more operations for a computer system to perform is provided. The interface can provide options that are selectable to cause an operation from a predetermined set of operations to be added to the workflow. Data indicating user selection of an option of the interface corresponding to a first operation in the predetermined set of operations is received. Code that specifies one or more custom operations is received. The workflow is defined to include (i) the first operation based on the data indicating the user selection and (ii) a second operation specified by the code.Type: GrantFiled: October 23, 2020Date of Patent: April 23, 2024Assignee: MicroStrategy IncorporatedInventors: Richard Gardner, Clayton Myers, Andrew Smith
-
Publication number: 20230115554Abstract: Assessment of cognitive function affected by brain injuries is achieved. This included, but is not limited to, assessment of cognitive function affected by brain injuries, for example injuries sustained during sporting activities. A virtual reality system is used to apply controlled cognitive loading to the subject, via a series of distinct test types which in combination apply an increasing cognitive load over time. Results are optionally assessed in conjunction with data from an instrumented mouthguard and/or Finite Element Analysis (FEA) model.Type: ApplicationFiled: March 10, 2021Publication date: April 13, 2023Inventors: Mike Vegar, Ben Nizette, Thomas Rau, Andrew Gardner
-
Patent number: 11290291Abstract: In a Power over Data Lines (PoDL) system that conducts differential data and DC power over the same wire pair, various DC coupling techniques are described that improve DC voltage coupling while attenuating AC common mode noise and avoiding mode conversion. A first CMC and AC coupling capacitors are connected in series between a PHY and a twisted wire pair. A DC power supply is DC coupled to the wires via a series connection of a DMC and either matched inductors or a second CMC. Coupled between the DMC and the inductors/CMC is an RC termination circuit comprising a first capacitor coupled to one leg and a matched second capacitor coupled to the other leg. The two capacitors are connected to the same resistor coupled to ground.Type: GrantFiled: May 8, 2019Date of Patent: March 29, 2022Assignee: Analog Devices International Unlimited CompanyInventors: Andrew Gardner, Gitesh Bhagwat
-
Patent number: 11258211Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.Type: GrantFiled: October 21, 2020Date of Patent: February 22, 2022Assignee: AB CONNECTORS LTD.Inventors: Marcus Davies, Andrew Gardner, David Whitworth
-
Patent number: 10940155Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.Type: GrantFiled: February 6, 2020Date of Patent: March 9, 2021Assignee: TLC Therapeutics, LLCInventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
-
Publication number: 20210057857Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.Type: ApplicationFiled: October 21, 2020Publication date: February 25, 2021Inventors: Marcus DAVIES, Andrew GARDNER, David WHITWORTH
-
Patent number: 10826252Abstract: There is described a method of establishing an electrical connection through a flexible planar material. The method involves attaching an intermediate coupling element to the flexible planar material so as to align an aperture defined by the intermediate coupling element with a hole through the flexible planar material, and coupling an electrical connector to the intermediate coupling element so as to permit electrical connection through the flexible planar material. In this way, the intermediate coupling element can be attached to the garment during the garment manufacture process, and subsequently the electrical connector can be coupled to the intermediate coupling element separately from the main garment manufacture.Type: GrantFiled: October 31, 2017Date of Patent: November 3, 2020Assignee: AB Connectors LtdInventors: Marcus Davies, Andrew Gardner, David Whitworth
-
Publication number: 20200179399Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.Type: ApplicationFiled: February 6, 2020Publication date: June 11, 2020Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
-
Patent number: 10561669Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.Type: GrantFiled: February 23, 2018Date of Patent: February 18, 2020Assignee: TLC THERAPEUTICS, LLCInventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
-
Publication number: 20200044875Abstract: In a Power over Data Lines (PoDL) system that conducts differential data and DC power over the same wire pair, various DC coupling techniques are described that improve DC voltage coupling while attenuating AC common mode noise and avoiding mode conversion. A first CMC and AC coupling capacitors are connected in series between a PHY and a twisted wire pair. A DC power supply is DC coupled to the wires via a series connection of a DMC and either matched inductors or a second CMC. Coupled between the DMC and the inductors/CMC is an RC termination circuit comprising a first capacitor coupled to one leg and a matched second capacitor coupled to the other leg. The two capacitors are connected to the same resistor coupled to ground.Type: ApplicationFiled: May 8, 2019Publication date: February 6, 2020Inventors: Andrew Gardner, Gitesh Bhagwat
-
Patent number: 10366344Abstract: A computer-implemented method for selecting features for classification may include (1) generating a matrix X, a column vector Y, and a matrix Z from a training dataset that includes a plurality of samples with a plurality of features, (2) generating an augmented matrix from the matrix X, the column vector Y, and the matrix Z, (3) identifying one or more most-relevant features from the plurality of features by iteratively applying a sweep operation to the augmented matrix, and (4) training a classification model using the most-relevant features from the plurality of features rather than all of the plurality of features. Various other methods, systems, and computer-readable media may have similar features.Type: GrantFiled: March 31, 2016Date of Patent: July 30, 2019Assignee: Symantec CorporationInventors: Nikolaos Vasiloglou, Jugal Parikh, Andrew Gardner
-
Patent number: 10250617Abstract: A computer-implemented method for detecting malware using machine learning may include (1) identifying data to be analyzed for malware, (2) classifying, using a classifier created by a combination of at least one deep learning neural network and at least one supervised data mining method, the data to be analyzed for malware, (3) determining, based on a predefined threshold, that the classification of the data indicates potential malware on the computing device, and (4) performing a security action based on the determination of potential malware on the computing device. Various other methods, systems, and computer-readable media are also disclosed.Type: GrantFiled: November 22, 2015Date of Patent: April 2, 2019Assignee: Symantec CorporationInventors: Andrew Gardner, Walter Bogorad, Jun Mao
-
Patent number: 10177491Abstract: There is described a connector assembly having a first connector part and a second connector part. At least one of the first connector part and the second connector part comprises at least one magnet for providing an attractive force between the first connector part and the second connector part to align the first connector part and the second connector part in a connected state. The first connector part comprises a guide track and the second connector part comprises a follower, the guide track being shaped to guide movement of the follower, under the influence of said attractive force, to a retaining position in which the follower engages an abutment surface on the first connector part to provide a retaining mechanism for retaining the first connector part and the second connector part in the connected state.Type: GrantFiled: October 13, 2017Date of Patent: January 8, 2019Assignee: AB CONNECTORS LTDInventors: Marcus Davies, Andrew Gardner, David Whitworth
-
Publication number: 20180360844Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.Type: ApplicationFiled: February 23, 2018Publication date: December 20, 2018Inventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman
-
Patent number: 10133071Abstract: Disclosed herein is a lens for a wearable projection system. The lens includes a lens blank and a holographic optical element. The holographic optical element can be removably attached to the lens. The holographic optical element is aligned to a position on the lens surface based on temporary alignment marks projected onto the lens.Type: GrantFiled: September 28, 2016Date of Patent: November 20, 2018Assignee: INTEL CORPORATIONInventor: Andrew Gardner Wade
-
Patent number: 10081799Abstract: This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.Type: GrantFiled: February 14, 2017Date of Patent: September 25, 2018Assignee: New England Biolabs, Inc.Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
-
Patent number: 10041051Abstract: This disclosure provides, among other things, a composition comprising: comprising a fusion protein comprising: (a) a DNA polymerase; and (b) a heterologous sequence-specific DNA binding domain. A method for copying a DNA template, as well as a kit for performing the same, are also described.Type: GrantFiled: February 14, 2017Date of Patent: August 7, 2018Assignee: New England Biolabs, Inc.Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
-
Publication number: 20180216098Abstract: This disclosure provides, among other things, a composition comprising: a 5? exonuclease; a strand-displacing polymerase; and optionally a single strand DNA binding protein and/or a ligase. A method for polynucleotide assembly to form a synthon, as well as a kit for performing the same, are also described.Type: ApplicationFiled: August 27, 2015Publication date: August 2, 2018Applicant: New England Biolabs, Inc.Inventors: Pei-Chung Hsieh, Luo Sun, Thomas C. Evans, Jr., Theodore B. Davis, Andrew Gardner
-
Patent number: 10037425Abstract: Suspicious file prospecting activity is detected based on patterns of file system access. A user's file system access is monitored over a specific time period. A sequence of the file accesses (e.g., represented as path names) made by the user during the time period is recorded. Distances between the recorded file accesses are determined, for example as edit distances. A distance sequence is recorded, comprising a record of the determined distances. The distance sequence is reduced to one or more baseline statistics describing the pattern of the user's access of the file system during the given period of time. At least one subsequent anomaly in the user's access of the file system is detected, by comparing at least one subsequently calculated statistic representing at least one subsequent pattern of the user's file system access to the at least one baseline statistic.Type: GrantFiled: August 26, 2015Date of Patent: July 31, 2018Assignee: Symantec CorporationInventors: Aleatha Parker-Wood, Andrew Gardner
-
Patent number: 9993486Abstract: A quetiapine fumarate composition for oral administration is provided comprising a pharmaceutically acceptable salt or solvate of quetiapine existing as a suspension in an aqueous carrier agent. The inventive liquid formulation demonstrates high bioavailability consistent with approved dosage forms, low agglomeration, reduced content of excipients commonly used in solid oral dosage forms and extended shelf life stability. Also provided is a method of manufacturing a liquid quetiapine suspension composition for oral administration and methods of administering therapeutically effective dosages of an oral liquid quetiapine suspension composition to patients in need thereof.Type: GrantFiled: June 19, 2017Date of Patent: June 12, 2018Assignee: TLC THERAPEUTICS, LLCInventors: Carl Tierney, Andrew Gardner, Jan Pick-Katolik, Stacey Powell, Mark Foley, Laurence Ramsey, Andrew Hardeman